Efavirenz 33342-0013
Product NDC
33342-0013- Manufacturer
- Macleods Pharmaceuticals Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 10, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA091579
Need to source Efavirenz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Efavirenz | 600 mg/1 |
Drug Class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 2B6 Inducers [MoA]Cytochrome P450 2C19 Inhibitors [MoA]
Packaging Options(1)
30 TABLET in 1 BOTTLE (33342-013-07)